The latest health news
WASHINGTON — A powerful Democratic lawmaker is interrogating the National Institutes of Health over its slow progress in addressing long Covid, citing a recent STAT investigation into the agency’s lack …
Read More
ORLANDO, Fla. — There was some drama at the American Association for Cancer Research annual meeting: stocks crashed, companies debuted new compounds and trial results, and a blood cancer mystery …
Read More
In the face of rising drug prices, health plan sponsors have quietly used a clever, but questionable tactic over the past few years to deflect costs. And now, some pharmaceutical …
Read More
WASHINGTON — After 9/11, Congress created an entirely new government agency to address the threat of terrorism, and Americans are still taking off their shoes in airports more than twenty years …
Read More
Dear Reader, From STAT’s first investigations in June 2021 revealing why the FDA gave the go-ahead for a marginally effective Alzheimer’s drug manufactured by Biogen, we have relentlessly stayed on …
Read More
An investigational Alzheimer’s disease treatment from Biogen and Eisai slowed the rate of cognitive decline by 27% in a clinical trial, the companies said Tuesday, meeting the goals of a …
Read More
Good Therapeutics, a private company that raised just $30 million in venture financing since its 2016 foundation, said Wednesday it had signed a deal to sell itself to Roche for …
Read More
The Food and Drug Administration on Monday approved an Eli Lilly drug that is the first-ever treatment for alopecia areata, an autoimmune disorder that triggers sudden hair loss. The once-daily …
Read More
Spare a thought for Illumina. The $56 billion dollar titan of genomics has become the world’s leading supplier of DNA sequencing technology. That’s been great for the company’s bottom line …
Read More